Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
T5O | Xetra | EUR | Delayed | |
T5O | TradeGate | EUR | Delayed | |
T5O | Frankfurt | EUR | Delayed |
bioXXmed AG reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 0.012411 million compared to EUR 0.00413 million a year ago. Net loss was EUR 0.31092 million compared to EUR 0.480053 million a year ago.
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Revenue | 0.004 | 0.004 | 0.002 | 0.002 |
Gross Profit | 0.004 | 0.004 | 0.002 | 0.002 |
Operating Income | -0.186 | -0.186 | -0.226 | -0.226 |
Net Income | -0.175 | -0.175 | -0.24 | -0.24 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Assets | 21.61 | 21.61 | 22.36 | 22.36 |
Total Liabilities | 0.189 | 0.189 | 0.587 | 0.587 |
Total Equity | 21.42 | 21.42 | 21.77 | 21.77 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -0.163 | -0.163 | -0.292 | -0.292 |
Cash From Investing Activities | -0.735 | -0.735 | ||
Cash From Financing Activities | -0.082 | -0.082 | 2.19 | 2.19 |
Net Change in Cash | -0.979 | -0.979 | 1.9 | 1.9 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review